Tianyi Jiang - 16 Mar 2026 Form 4 Insider Report for AvePoint, Inc. (AVPT)

Signature
/s/ Brian Michael Brown, Attorney-in-Fact
Issuer symbol
AVPT
Transactions as of
16 Mar 2026
Net transactions value
$0
Form type
4
Filing time
18 Mar 2026, 20:50:47 UTC
Previous filing
17 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Jiang Tianyi Chief Executive Officer, Director C/O AVEPOINT, INC., 525 WASHINGTON BOULEVARD, SUITE 1400, JERSEY CITY /s/ Brian Michael Brown, Attorney-in-Fact 18 Mar 2026 0001865596

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVPT Common Stock Award +147,338 +6.8% $0.000000* 2,299,627 16 Mar 2026 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVPT Stock Option (Right to Buy) Award +252,609 +10% $10.52* 2,756,670 16 Mar 2026 Common Stock 252,609 $10.52 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This security represents the Issuer's common stock as well as restricted stock units (each, an "RSU") granted to the Reporting Person under the Issuer's 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
F2 Represents performance-based RSUs ("PRSUs") based upon two metrics: Annual recurring revenue compounded annual growth rate for the years 2026-2028 (70% weighted) and FY 2028 GAAP profitability (30% weighted). Actual payouts may represent 50% to 200% of granted value. These PRSUs will fully vest upon certification of the actual payouts by the Issuer's Compensation Committee after the performance period ends.
F3 Includes non-RSU common stock as well as aggregate vested and unvested RSUs held by the Reporting Person subject to the vesting schedules previously reported on Table I of Form 4s filed with the Securities and Exchange Commission on September 3, 2021, March 22, 2022, March 23, 2023, March 7, 2024, and March 18, 2025.
F4 This security represents options to purchase the Issuer's common stock granted to the reporting person under the Issuer's 2021 Equity Incentive Plan. Each option represents the contingent right to receive, upon exercise of the option, one share of the Issuer's common stock.
F5 25% of the shares underlying these options will vest on March 16, 2027, and the remaining options vest in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.